O-Tolylamine

O-Tolylamine

SCHEMBL28469331

Cc1ccccc1N.Cc1ccccc1N.N=C=O.N=C=O

nearest known ligand 0.68

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 6/20 0.68
CYP3A4 P08684 5/20 0.68
CD44 P16070 1/20 0.46
TSHR P16473 6/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
CASP1 P29466 2/20 0.41
ALOX15 P16050 1/20 0.41
CASP7 P55210 1/20 0.41
ACHE P22303 1/20 0.41
TP53 P04637 2/20 0.40
PIK3CA P42336 1/20 0.40
MAPK1 P28482 1/20 0.40
ALDH1A1 P00352 7/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
KDM4E B2RXH2 2/20 0.36
HPGD P15428 1/20 0.36
GAA P10253 2/20 0.35
MEN1 O00255 1/20 0.35
USP2 O75604 1/20 0.35
HTT P42858 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
O-Tolylamine SCHEMBL272719 1.00 TDP1 (0.68) TDP1CYP3A4CD44TSHRSMN1; SMN2
O-Tolylamine SCHEMBL6418354 1.00 TDP1 (0.68) TDP1CYP3A4CD44TSHRSMN1; SMN2
O-Tolylamine SCHEMBL29393491 1.00 TDP1 (0.68) TDP1CYP3A4CD44TSHRSMN1; SMN2
O-Tolylamine SCHEMBL112023 1.00 TDP1 (0.68) TDP1CYP3A4CD44TSHRSMN1; SMN2
O-Tolylamine SCHEMBL28417386 0.92 CYP3A4 (0.58) TDP1CYP3A4CD44TSHRSMN1; SMN2
O-Tolylamine SCHEMBL27660087 0.90 CYP3A4 (0.75) TDP1CYP3A4CD44TSHRSMN1; SMN2
O-Tolylamine SCHEMBL330781 0.86 CYP3A4 (0.68) TDP1CYP3A4CD44TSHRSMN1; SMN2
O-Tolylamine SCHEMBL9613766 0.84 CYP3A4 (0.94) TDP1CYP3A4CD44TSHRSMN1; SMN2
O-Tolylamine SCHEMBL8469060 0.84 CYP3A4 (0.94) TDP1CYP3A4CD44TSHRSMN1; SMN2
O-Tolylamine SCHEMBL31145800 0.84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108147980-B Method for producing diisocyanates by phosgenation of diamine suspensions 科思创德国股份有限公司 2020-10-23 CN disclosed